Bos, Harry (Sanguin Blood Supply 201409 Director of Diagnostics) |
n. a. |
Sanquin (Group) |
Netherlands |
Bos, Jasper (Forbion 202105 General Partner before M Ventures + Netherlands Vaccine Institute) |
General Partner (venture partner) |
Forbion (Group) |
Netherlands |
Bosc, Jessica (JSR Corp 201903– Director Business Development + Licensing for Selexis in Boston) |
Business Development Manager / Strategy Manager |
JSR Corporation (Group) |
United States (USA) |
Boshoff, Chris (Pfizer 201610 Head of Immuno-Oncology, Early Developm + Translational Oncology) |
Research & Development Manager |
Pfizer (Group) |
United States (USA) |
Bosio, Andreas (Miltenyi Biotec 202007 Senior RnD Manager) |
Research & Development Manager |
Miltenyi Biotec (Group) |
Germany |
Bosisio, Lorenzo (EffRx Pharmaceuticals 201607– CEO before CCO since 2013 before Amgen + Alexion + PwC + Tissot Medical) |
Chief Executive Officer (CEO) |
EffRx Pharmaceuticals S.A. |
Switzerland |
Bosker, Gideon (DarwinHealth 201811 CEO) |
Chief Executive Officer (CEO) |
DarwinHealth (US) |
United States (USA) |
Boss, Christopher (NürnbergMesse 202108 Director of MEdtecLIVE) |
Product Manager (personnel) |
NürnbergMesse GmbH (Messe Nürnberg) |
Germany |
Bossert, Michael (Enamine Ltd 201201 Business Development Director) |
Business Development Manager / Strategy Manager |
Enamine Ltd. (UA) |
Ukraine |
Bossko, Andreas (Axolabs 201603 Managing Director (CFO) before Roche Kulmbach + Ribopharma) |
Managing Director |
LGC (Group) |
Germany |
Bosslet, Klaus (Roche 201309 Head of Roche Discovery Oncology in Penzberg) |
Research & Development Manager |
Roche (Group) |
Germany |
Bosson, Oskar (BioArctic 202408 VP Communications + IR formerly Swedish Orphan Biovitrum) |
Public Relations Manager / Investor Relations Manager |
BioArctic AB (Nasdaq Stockolm: BIOAB) |
Sweden |
Bott, Martin (BioVersys 202105– CFO before AMR Action Fund + Eli Lilly) |
Chief Financial Officer (CFO) |
BioVersys AG |
Switzerland |
Botti, Paolo (Arisgen 2007) |
n. a. |
ArisGen S.A. |
Switzerland |
Botti, Simone (Inkef Capital 202104 Junior Partner before Metabomed + MS Ventures Israel Bioincubator Fund) |
Partner (venture partner) |
ABP (Stichting Pensioenfonds) (Group) |
Netherlands |
Botzler, Claus (Numares 202006 CBO) |
Chief Business Officer (CBO) |
Numares (Group) |
Germany |
Bou Dib, Peter (Sino Biological 202405 at Sino Biological Europe GmbH) |
Sales Manager / Marketing Manager |
Sino Biological (Group) |
Germany |
Bouchon, Axel (ARCH Venture 202112– Venture Partner + BrainGames before Leaps by Bayer + Moderna Therapeutics) |
Venture Partner |
ARCH Venture (Group) |
United States (USA) |
Bouet, Laurence (Innopsys 201303 Executive + Sales Director) |
Sales Manager / Marketing Manager |
Innopsys (Group) |
France |
Boulais Raveneau, Amélie (Sartorius 201803 Vaccine Platform Marketing Manager at SSB) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
France |
Boulanger, Dimitri (Céleste Management 202012 CEO) |
Chief Executive Officer (CEO) |
Céleste Management S.A. |
Switzerland |
Boulnois, Graham (SV Life Sciences 201105 Senior Partner) |
Partner (venture partner) |
SV Health Investors (Group) |
United Kingdom (GB) |
Boulud, Pierre (Mérieux 202310 CEO of bioMèrieux joined 11/16 before Ipsen + Boston Consulting + Bossard Consultants) |
Chief Executive Officer (CEO) |
Mérieux (Group) |
France |
Bourdon, Christophe (Leo Pharma 202204– CEO before Orphazyme + Amgen + Alexion) |
Managing Director |
Leo Pharma (Group) |
Denmark |
Bourla, Albert (Pfizer201605 Group President Global Innovative Pharma + Vaccines, Oncology + Consumer Healthcare) |
President/Director/Head Business Group/Unit/Division |
Pfizer (Group) |
United States (USA) |
Boury, Guillaume (Telos Impact 202309 Investment Manager) |
Investment Manager |
Telos Impact |
|
Bout, Bram (ProFibrix BV 200703– CTO before Crucell VP Protein Production) |
Research & Development Manager |
Novartis (Group) |
Netherlands |
Bouterfa, Hakim (Eckert & Ziegler 202306 CMO formerly Managing Director of OctreoPharm Sciences GmbH) |
Chief Medical Officer (CMO) |
Ipsen (Group) |
Germany |
Bouvier, Frédéric (Minapharm 202211 Head Corp Development, BusDev + Licensing at MiGenTra) |
Business Development Manager / Strategy Manager |
Minapharm (Group) |
Germany |
Boven, Karl-Heinz (Multi Channel Systems MCS Founder) |
Company Founder |
Harvard Bioscience (Group) |
Germany |
Boxheimer, Carmen (Danaher 201709 Sciex) |
Sales Manager / Marketing Manager |
Danaher (Group) |
Germany |
Boyce, John (BrickBio 202009 CEO + CO-Founder of TigeGene formerly Exosome Diagnostics 201806 CEO) |
Chief Executive Officer (CEO) |
TigerGene LLC |
United States (USA) |
Boyle, Robert (Sentinel Oncology 201605 CEO) |
Chief Executive Officer (CEO) |
Sentinel Oncology Ltd. |
United Kingdom (GB) |
Bozicevic, Falko (GoingPublic Media 200902 Editor) |
Editor / Publisher |
GoingPublic Media AG (FSE: WKN 761 210) |
Germany |
Bozotti, Carlo (STMicroelectronics 200702 Pres + CEO) |
Chief Executive Officer (CEO) |
STMicroelectronics (Group) |
Switzerland |
Braam, Stefan (Ncardia 201709– CEO before Pluriomics) |
Chief Executive Officer (CEO) |
Kiniciti Bio (WCAS invesment platform) (Group) |
Belgium |
Brabeck-Letmathe, Peter (Nestlé –200711– Chairman + CEO) |
Chief Executive Officer (CEO) |
Nestlé (Group) |
Switzerland |
Bracco, Fulvio Renoldi (Bracco 201710 CEO at Bracco Imaging SpA) |
Chief Executive Officer (CEO) |
Bracco (Group) |
Italy |
Bracht, Franzpeter (Celonic 201711– COO before Glycotope + Aplagen + Ernst & Young + Kienbaum) |
Chief Financial Officer (CFO) |
Celonic (Group) |
Switzerland |
Bradley, Denise (Roche 202310 Communications at Spark Therapeutics) |
Public Relations Manager / Investor Relations Manager |
Roche (Group) |
United States (USA) |
Bradner, James E. (Jay) (Novartis 2016 President Novartis Institutes for BioMedical Research before Broad Institute) |
Professor |
Novartis (Group) |
Switzerland |
Bradway, Robert A. (Amgen 201403 CEO before CFO before Morgan Stanley) |
Chief Executive Officer (CEO) |
Amgen (Group) |
United States (USA) |
Braemisch, Fabian (Gilde Healthcare 201801– Partner of Healthcare Buy-out Team before Bridgepoint + Goldman Sachs) |
Partner (venture partner) |
Gilde Investment (Group) |
Germany |
Braggio, Simone (Evotec 202210 EVP, Partnership Management Excellence + Board Member at EXTEND) |
Business Development Manager / Strategy Manager |
Italy (govt) |
Italy |
Braglia, Riccardo (Helsinn Healthcare 200602 Managing Director) |
Managing Director |
Helsinn (Group) |
Switzerland |
Braguglia, Diego (VI Partners 201603) |
Investment Manager |
VI Partners AG |
Switzerland |
Brahms, Julie (Eppendorf 201604 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Eppendorf (Group) |
Germany |
Brain, Christopher (Chris) (Osteolabs 202105– General Manager of Osteolabs UK Ltd formerly Abbott + Cepheid + Roche Dx) |
General Manager (management) |
Osteolabs (Group) |
United Kingdom (GB) |
Brambilla, Gabriele (Alira Health 202005 CEO) |
Chief Executive Officer (CEO) |
Alira Health (CMC Consulting Boston) (Group) |
United States (USA) |
Brand, Alexandra (BASF 201305 SVP Animal Nutrition Business) |
President/Director/Head Business Group/Unit/Division |
BASF (Group) |
Germany |
Brand, Florian (ATAI Life Sciences 202004 CEO) |
Chief Executive Officer (CEO) |
Atai Life Sciences AG |
Germany |
Brand, Sabine (SBR Consulting 201504) |
Consultant (economic/technology) |
|
Germany |
Brandau-Krug, Barbara (ACD/Labs 200909– Account Manager Advanced Chemistry Development Germany GmbH) |
Sales Manager / Marketing Manager |
Advanced Chemistry Development (ACD/Labs) (Group) |
Germany |
Brandenberg, Nathalie (Sun Bioscience 202310 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
|
Switzerland |
Brandenburg, Mario (Member of German Parliament + Technology Policy Spokesman of FDP) |
n. a. |
|
|
Brander, Sonja |
n. a. |
Bayer (Group) |
Switzerland |
Brandicourt, Olivier (Sanofi 201508–201908 CEO before CEO of Bayer HealthCare before Pfizer Inc RETIRED 9/19) |
Chief Executive Officer (CEO) |
Sanofi (Group) [since May 2011] |
France |
Brandis, Hendrik (Earlybird 201807 Managing Director) |
Managing Director |
Earlybird (Group) |
Germany |
Brandkamp, Michael (ECBF 202001– General Partner before Managing Director at High-Tech Gründerfonds) |
Managing Director |
ECBF (European Circular Bioeconomy Fund) (Group) |
Germany |
Brandon, Roslyn (Immunexpress 201403 CEO) |
Chief Executive Officer (CEO) |
Immunexpress (Group) |
United States (USA) |
Brandt, Ralf (vivoPharma 201504 CEO + Founder before Head of Tumor Biology at Novartis AG) |
Chief Executive Officer (CEO) |
vivoPharm (Group) |
Australia |
Brandt, Stephan (Germany (govt) 201504 BMG Referat Biotech) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
Brandt, Werner (SAP 200102– CFO before Fresenius Medical Care before Baxter Deutschland) |
Chief Financial Officer (CFO) |
SAP (Group) |
Germany |
Brangwynne, Clifford P. (Princeton Univ 202011– Prof Dept of Chemical + Biological Engineering) |
Professor |
Princeton University |
United States (USA) |
Braspenning, Joris (Medicyte GmbH 201207 Managing Director (CEO + CSO)) |
Managing Director |
Medicyte GmbH |
Germany |
Brass, Laura (Novartis 201912 Managing Director at NVF) |
Managing Director |
Novartis (Group) |
Switzerland |
Brauer, Peer (Sartorius 201309 VP Finance at SSB) |
Chief Financial Officer (CFO) |
Sartorius (Group) |
France |
Braun, Anna Maria (B Braun 201807 President Asia Pacific) |
President/Director/Head Business Group/Unit/Division |
B. Braun (Group) |
Germany |
Braun, Dagmar (B Braun 202203 at Braun Beteiligungs GmbH) |
n. a. |
BBG/Braun Group (Group) |
Germany |
Braun, Helge (Germany (govt) 201011 Staatssekretär BMBF) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
Braun, Julia (Baker McKenzie 202205) |
Attorney / Lawyer |
Baker McKenzie LLP |
United States (USA) |
Braun, Volker (Evotec 202008– Head of Global Investor Relations + ESG) |
Public Relations Manager / Investor Relations Manager |
Evotec (Group) |
Germany |
Braunschweiler, Lukas (Sonova Holding + Tecan Board Chairman) |
Board member, non-executive |
Tecan (Group) |
Switzerland |
Braunstein, Guy (Actelion 201108 Head Clinical Development) |
Clinical Research Manager |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
Bravetti, Paul (Brenus Pharma 202301 CEO) |
Chief Executive Officer (CEO) |
Brenus Pharma S.A. |
France |
Bravo, Eduardo (Life Sciences Partners 202103– Partner + CEO of EBAC before Nordic Nanovector + TiGenix + Cellerix) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Belgium |
Brea-Krüger, Mariana (IMI Consulting 200503 Managing Director) |
Managing Director |
IMI Consulting GmbH |
Germany |
Brecht, René (ProBioGen 2002– VP Process Science + Manufacturing before Univ Leipzig) |
n. a. |
Minapharm (Group) |
Germany |
Brégand, Eric (TEMIS 200809 CEO) |
Chief Executive Officer (CEO) |
Expert System (Group) |
France |
Breidbach, Andreas (EU (govt) 200609– EC-JRC-IRMM) |
Researcher (university / research institute) |
EU (govt) |
Belgium |
Breimesser, F. H. |
n. a. |
Siemens (Group) |
Germany |
Breiner, Klaus (BB Biotech Ventures + Vaximm 201605 Executive Chairman) |
Board member, executive |
Vaximm (Group) |
Switzerland |
Breitenstein, Urs (Nemis Technologies 202202 CFO + Co-Founder) |
Chief Financial Officer (CFO) |
Nemis Technologies AG |
Switzerland |
Bremer, Ralf (Gerstel 201402 Managing Director, RnD + Production) |
Managing Director |
Gerstel (Group) |
Germany |
Bremus, Christoph (Phenospex 201909– Chief Commercial Officer before Eppendorf + DASGIP) |
n. a. |
OTHER |
|
Brenker, Kathrin (Opto Biolabs 201906– Managing Director + Founder) |
Managing Director |
Opto BIolabs GmbH (formerly UG) |
Germany |
Brennan, John (EuropaBio –201808 Secretary General LEFT 9/18) |
lobbying |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
Brennecke, Marcus (EQT Partners 201706 Partner + Investment Advisor to EQT VII fund) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
|
Brennecke, Thomas (Staatz Business Development & Strategy) |
consulting (economic) |
Staatz Business Development & Strategy – Dr. Irina Staatz-Granzer |
Germany |
Brenning, Thomas |
n. a. |
Helaba (Group) |
Germany |
Bresch, Heather (Mylan 201310 CEO) |
Chief Executive Officer (CEO) |
Viatris (Group) |
United States (USA) |
Bressi, Jeanette (MorphoSys 202012 Director US Communications) |
Public Relations Manager / Investor Relations Manager |
Novartis (Group) |
United States (USA) |
Brett, Catherine (Innovative Medicines Initiative 201807 External Relations Manager) |
President/Director/Head Business Group/Unit/Division |
Innovative Health Initiative (IHI JU) |
EU (European Union) |
Brett, Gerard (Vivasure Medical 201609 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Vivasure Medical Ltd. |
Ireland, Republic of |
Breu, Jessica (Immunic 201904 Manager IR + Communications) |
Public Relations Manager / Investor Relations Manager |
Immunic (Group) |
Germany |
Breu, Raymund (Novartis –2001003 CFO retires 3/10) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
Breuer, Sebastian (Genetics Company 200608 Program Manager Diagnostics) |
Product Manager (personnel) |
Genetics Company Inc., The |
Switzerland |
Breugelmans, Matthias (Elastrin 202209 CEO) |
Chief Executive Officer (CEO) |
Elastrin Therapeutics |
|
Breuker, Kathrin (Univ Innsbruck 201005 Principal Investigator Institute of Organic Chemistry) |
Researcher (university / research institute) |
University of Innsbruck |
Austria |
Brewis, Neil (F-Star 201611 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sino Biopharm (Group) |
United Kingdom (GB) |